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GENETIC DISORDERS - DEVELOPMENT
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Mutations in the CLCNS gene in Japanese patients with familial
idiopathic low-molecular-weight proteinuria. Familial idiopathic low-
molecular-weight proteinuria (FILMWP) is a renal proximal tubulopathy
that occurs predominantly in males. FILMWP is characterized by mild
proteinuria consisting of low-molecular-weight proteinuria, aminoaciduria
and relatively conserved renal function, but without rickets. To determine
whether FILMWP is related to the CLCN5 gene, which is responsible for
Dent's disease and two related disorders, we analyzed the CLCN5 gene
from four Japanese families with FILMWP. We identified two novel
mutations: one was a single base insertion at codon 520 serine in exon 10
and the other was a single base deletion at codon 403 tyrosine in exon 8.
These mutations caused a shift in the reading frame, resulting in synthesis
of truncated CLC5 proteins that lacked 220 (29%) and 314 (42%) amino
acids, respectively. These mutations were demonstrated to cosegregate
with the disease in two families, respectively. We conclude that the
CLCN5 gene is responsible for this proximal renal tubulopathy in some
Japanese families and that FILMWP is possibly a variant of Dent's
disease.
Familial idiopathic low-molecular-weight proteinuria
(FILMWP) is a renal tubular disorder characterized by: (i) mild
proteinuria consisting of low-molecular-weight (LMW) protein-
uria and low grade albuminuria, usually without hematuria; (ii)
aminoaciduria and then glycosuria; (iii) no growth retardation;
(iv) absence of acidosis; (v) normal renal function in young
subjects; and (vi) predominantly appearing in males, which has
been noted in Japanese boys [1, 21. We reported that FILMWP
patients of an advanced age and of the same family had less
favorable laboratory data concerning azotcmia and hypophos-
phatemia [3]. This disease seems to have clinical heterogeneity.
Dent's disease is characterized by LMW proteinuria, hypercal-
ciuria, nephrocalcinosis, nephrolithiasis, rickets and progressive
renal failure [4]. The disease has phenotypic similarities to
X-linked recessive nephrolithiasis (XRN) [5] and X-linked reces-
sive hypophosphatemic rickets (XLRH) [61. However, there are
important differences, as rickets is absent in XRN, and nephro-
ealeinosis and moderate renal failure are more notable in XLRH.
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Fisher et al described the isolation and characterization of the
complete open reading frame of the human CLCN5 gene,
mapped to Xpll.22, which is predicted to encode a protein 746
amino acids, with significant homology to all known members of
the CLC family of the voltage-gated chloride channel [71. They
showed that the coding region of the CLCN5 gene is organized
into 12 exons, spanning 25 to 30 kb of genomic DNA. Lloyd et a!
reported that the CLCN5 gene is responsible for three disorders
of hypercalciuric nephrolithiasis [81.
To determine whether FILMWP in Japanese families is a
disorder related to Dent's disease, XRN and XLRH in Cauca-
sians, we analyzed the CLCN5 gene from Japanese families with
FILMWP and identified two novel mutations. We believe that the
CLCN5 gene is responsible for the proximal renal tubulopathy in
some Japanese families.
METHODS
Materials
To amplify all exons 1 to 12 of the CLCN5 gene, 15 pairs of
oligonucleotide primers were synthesized based on flanking intron
and exon sequences of the gene [71. The sequences of the
oligonucleotide primers were as follows:
exon 1: IA: 5 '-TGATGTGATATGGCTGCAAG-3'
exon 1: 1B: 5'-TGGGGYFGATAAAGAAATAC-3'
exon 2: 2A: 5'-AATGTCTA'TTFCTTGTFCAA-3'
exon 2: 2B: 5'-ACCCATGTGCCATC1TTTGT-3'
exon 3: 3A: 5'-CCAATGTVVFCTCA'VTTFCC-3'
exon 3: 3B: 5'-TFT'GAAAACTAACAG1TTAC-3'
exon 4: 4A: 5 '-AAC'VflTGGCCYTTCCCTCCCT-3'
exon 4: 4B: 5 '-CTCATAAAACATCACTACAT-3'
exon 5: 5EA: 5 '-GGAGCCTTTGCCTAATAGT-3'
exon 5: 5EB: 5' -CTCAGGGATTCCAGAGCCACAG-3'
exon 6: 6A: 5'-cAATCYFFCTGTGTFFAACC-3'
exon 6: 6B: 5' -GACTATTAAGGCCATTCATF-3'
exon 7: 7EA: 5 '-GTC'VfGTCGGCTGCAGCAGC-3'
exon 7: 7EB: 5' -CTCTFCAAGGCTGAATAATACT-3'
cxon 8: 81A: 5 '-TGCTT1TCTCACC'VFC'VITC-3'
exon 8: 81B: 5'-ATAAACAGTGCTCCCCACAG-3'
exon 8: 82A: 5 '-CCATrCA'TTCTGCTGGGCAT-3'
exon 8: 82B: 5'-GGAGTCCAGAAGGCCACAGT-3'
exon 8: 83A: 5'-CAAGTGAGCTCATITITCTGAG-3'
exon 8: 83B: 5'-ACTGAGTCCCAAAAGAATTC-3'
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Fig. 1. PCR-SSCP.silver staining analysis. Amplified DNAs were denatured at 94°C for three minutes and electrophoresed on 7.5% polyacrylamide
gels with 6% glycerol at 4°C at 100 volts for 2 to 6 hours. The DNA was detected after silver staining. SSCP in exon 10 (A) and exon 8 (B). Abbreviations
are: C, normal male control; L2 and L3, patients L2 and L3. Compared to control samples, mobilities of amplified DNAs of the patients were clearly
altered, as indicated by arrowheads.
exon 9: 9A: 5'-ACCATCTATflTGGTYFCTC11I'-3'
exon 9: 9B: 5'-TGAAATJ'AATGCAAACACTA-3'
exon 10: lOlA: 5 '-GAGTAGACTGTGTCTA1TITC-3'
exon 10: 101 B: 5 '-ATCACATCCATTGCCAGGGT-3'
exon 10: 102A: 5 '-T[TCYFGAAGCCAAAGAAGAG-3'
exon 10: 102B: 5'-ACTATCCCC'TTfCTGAAATC-3'
exon 11: hA: 5'-AA1TFGTflTTT1TCCTFCTGTTFG-3'
exon 11: 11B: 5'-AITI'GACYTCACTCAAGACT-3'
exon 12: 12A: 5'-TTVFGTA'flTGTGTVFGTCT-3'
exon 12: 12B: 5'-TFCCCGCTTTACATCCAGAACT-3'
Genomic DNAs were extracted from peripheral leukocytes
from four unrelated Japanese individuals with FILMWP, accord-
ing to the standard method [9]. Genomic DNA was amplified in
vitro by polymerase chain reaction (PCR) [10, 11]. PCR conditions
have been described elsewhere [12]. For single strand conforma-
tion polymorphism (SSCP) analysis [13], the amplified DNA was
denatured at 94°C for three minutes and electrophoresed under
non-denaturing conditions on 7,5% polyacrylamide gels with 6%
glycerol at 4°C at 100 volts for two to six hours. The DNA was
detected after silver staining [14]. The amplified DNA was
subcloned into the pUC18 vector, and sequenced using a DNA
sequencer, GENESCAN Model 373A and Taq Dye Deoxy Ter-
minator Cycle Sequencing Kit (Applied Biosystems).
For gene tracking in patient L2, normal (1OEN) and mutant
(1OEM) primers were synthesized based on the sequence of exon
10 [7]. The sequences of oligonucleotide primers were:
I OEN: 5' -GACTCGGATGACTGTflTC-3'
1OEM: 5'-GACTCGGATGACTG'TTT' TC-3'
DNAs were extracted from peripheral leukocytes of L2 family
members, and amplified with primers 1OEN/IO1B or 1OEN/102B
(wild-type allele), and with primers IOEM/1OIB or IOEM/102B
(mutant allele), then electrophoresed on a 1.5% agarose gel.
For gene tracking in patient L3, normal (83EN) and mutant
(83EM) antisense primers were synthesized based on the se-
quence of exon 8 [7]. The sequences of oligonucleotide primers
were:
83EN: 5'-TGTGTTGAAACGGTTCTCA T-3'
83EM: 5' -TGTGTTGAAACGGTTCTCA A-3'
DNAs extracted from L3 family members were amplified with
primers 8IAJS3EN or 82A/83EN (wild-type allele), with primers
81A/S3EM or 82A/83EM (mutant allele), and then electropho-
resed on a 1.5% agarose gel.
Patients
Patient L2 was a seven-year-old boy with severe proteinuria (1
g/day), consisting of LMW proteinuria such as beta-2 microglobu-
lin (2m; 56,000 pg/liter), lysozyme (22.2 .tg/ml), csl-microglobu-
lin (70.9 mg/liter), and aminoaciduria. Glycosuria and acidosis
were absent. The patient's father had severe proteinuria (2 g/day),
including LMW proteinuria (/32m, 130,000 ,ag/liter). Hypokale-
mia, hypophosphatemia, glycosuria, phosphaturia, aminoaciduria
and reduced urine concentrating ability were also present. The
patient's mother and sister had mild elevated urinary 2m. A
paternal cousin, two paternal uncles and a maternal uncle among
family L2 members also had LMW proteinuria detected by
screening for f32m. In addition, there were several abnormalities:
aminoaciduria in all 6, phosphaturia in 4 of 6, hypercalciuria in all
6 and glycosuria in 2 of 6 affected males. Tubular dysfunction was
more severe in the older subjects, but acidosis, rickets and renal
failure were not present. The case has been described in detail
elsewhere [3].
Patient L3 was a 7-year-old boy with mild proteinuria that was
initially found at a urinary screening in school children, which
consisted of LMW proteinuria identified by 132m (31,000 j.g/liter),
lysozyme (16.0 itg/ml), and aminoaciduria. Urinary calcium excre-
tion was normal (0.4 mg/kg/day). Acidosis was not evident.
Glomerular filtration rate, urine concentrating ability and reab-
sorption of phosphate (%TRP) were normal. The maternal
grandfather had mild proteinuria (1+, by dipstick) and elevated
urinary 2m (42,000 pg/liter). The urinary exeretional calcium
creatinine ratio was normal (0.19). Acidosis was not evident. The
patient's mother and a younger sister had slightly elevated levels
of urinary 132m (437 and 4600 pg/liter, respectively). The patient's
father, sister, maternal uncle and grandmother had normal uri-
nary f32m levels. There was no rickets or incidence of renal failure
in this family.
RESULTS
We screened exons 1 to 12 of the CLCN5 gene for mutations,
using PCR-SSCP analysis. As shown in Figure 1, mobilities of the
amplified DNAs of patients L2 and L3 were clearly different from
those of control samples with regard to exons 10 and 8, respec-
tively.
In patient L2, sequencing of amplified products revealed a
single base "T" insertion at codon 520 serine in exon 10 (Fig. 2A)
[7]. This mutation caused a shift in the reading frame of seven
amino acids and introduced a premature termination signal TGA
at codon 527. This mutation resulted in synthesis of the truncated
CLC5 protein that lacked 220 amino acids (29%) at its carboxyl
terminus (Fig. 3A).
For gene tracking in the L2 family, we synthesized primers
1OEN to detect a wild-type allele and 1OEM for a mutant allele. A
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A
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Fig. 2. Partial nucleotide sequences of PCR amplified DNAs. (A) The mutation in patient L2 proved to he a single base "T" insertion (indicated by
an arrowhead) at codon 520 serine in exon 10 [7]. (B) In patient L3, the mutation was a single base "A" deletion (indicated by an arrowhead) at codon
403 tyrosine in exon 8.
fragment of mutant allele was positive in the patient (111), the
father (13), two paternal uncles (11 and 12) and a cousin (113) (Fig.
4). The patient's sister (112) and mother (14) were heterozygous
both with the same mutant allele and a wild-type allele. Since the
patient's cousin (113) had a mutant allele, his aunt (15), who did
not have a genetic examination, was probably heterozygous,
although she had a normal urinaly 2m level (82 .tg/liter). To
exclude PCR errors, the results were confirmed by three other
independent amplifications, and by using primers IOEN/1OIB and
IOEM/1OIB instead of 1OEN/102B and 1OEM/102B, respectively
(data not shown).
In patient L3, sequencing of amplified products revealed a
single base "A" deletion at codon 403 tyrosine in exon 8 (Fig. 2B)
[71. This mutation caused a shift in the reading frame of 30 amino
acids and introduced a premature termination signal TAA at
codon 433. This mutation resulted in synthesis of the truncated
CLC5 protein that lacked 314 amino acids (approximately 42%)
at its carboxyl terminus (Fig. 3B).
For gene tracking in the L3 family, we synthesized primers
83EN to detect a wild-type allele and S3EM for a mutant one. A
fragment of the wild-type allele was positive in the father (112), a
maternal grandmother (12) and uncle (Ill). A fragment of the
mutant allele was positive in the patient (1111) and maternal
grandfather (Ii) (Fig. 5). The patient's mother (113) and two
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Fig. 3. The amino acid sequence and schematic representation of deduced CLC5 proteins in patients [7, 8]. (A and B, top) Deduced amino acid
sequences. Amino acid numbers start at the translation initiator methioninc f 7]. The mutations are indicated by asterisks, and stop codons by pound
signs. (A and B, bottom) Deduced CLC5 proteins in patients indicated by solid lines and gray columns. The change region of the protein is indicated
by a gray line and a diagonal striped column. The absent region of the protein is indicated by broken lines and columns. Transmembrane domains
D1-D12 [7] are shown by columns with a number. The CLCN5 mutations reported previously are indicated by cireles (Dent's disease), squares (XRN)
and a triangle (XLRH), respectively [8]. Our mutations are indicated by asterisks. (A) The mutation at codon 520 in patient L2 caused a shift in the
reading frame of seven amino acids and introduced a premature termination signal at codon 527. The deduced protein was change of DII and absence
from D12 to the C-terminal region of the protein. (B) The mutation at eodon 403 in patient L3 caused a shift in the reading frame of 30 amino acids
and introduced a premature termination signal at codon 433. The deduced protein was change of the D8-D9 loop and the D9, and absence from the
partial region of D9 to the C-terminal region of the protein.
Fig. 4. Pedigree of patient L2 and gene
tracking by PCR with normal and mutant
primers. (A) Pedigree of patient L2. Symbols
are: (c) obligate female carrier; (U) affected
male. The person for whom clinical and/or
genetic examinations were not done is indicated
by an asterisk. Patient (Ill) is indicated by an
arrowhead. (B) Amplification of DNAs with
normal primers IOEN/lO2B (lane n) and
mutant primers 1UEM/102B (lane m) and
electrophoresis on a 1.5% agarose gel. C is a
normal male control. M is the 1 kh ladder
marker. The lanes correspond to the family
member immediately above them in (A). The
bp patient (Ill), the patient's father (13), twopaternal uncles (ti and 12) and a cousin (113)
had a mutant allele (a 418 bp fragment) alone.
418 The patient's mother (14) and sister (112) had
417 both mutant and wild-type (a 417 hp fragment)
alleles, indicating they were heterozygous for
the gene.
sisters (1112 and 1113) were heterozygous both with wild-type and
mutant alleles. However, the patient's sister (1112) had normal
urinary f32m levels (100 rg/liter). To exclude PCR errors, the
results were confirmed by three other independent amplifications,
and by using primer 81A/83EN and 81A/83EM instead of 82A/
83EN and 82A/83EM, respectively (data not shown).
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Fig. 5. Pedigree of patient L3 and gene
tracking by PCR with normal and mutant
primers. (A) Pedigree of patient L3. Symbols
are: (0) unaffected female; (LII) unaffected
male; (®) obligate female carrier; () affected
male. (B) Amplification of DNAs with normal
primers 82A183EN (lane n) and mutant primers
82A/83EM (lane m) and electrophoresis on a
1.5% agarose gel. C is a normal male control.
M is the 1 kb ladder marker. The lanes
correspond to the family member immediately
above them in (A). Patient (1111) and a
maternal grandfather (Ii) had a mutant allele
(a 266 bp fragment) alone. The father (112), a
bp maternal grandmother (12) and uncle (Ill) had
a wild-type allele (a 267 bp fragment) alone.267 The patient's mother (113) and two sisters (1112
266 and 1113) had both mutant and wild-type alleles,
indicating they were heterozygous for the gene.
DISCUSSION
We examined the CLCN5 gene in four unrelated Japanese
patients with familial idiopathic low-molecular-weight proteinuria
(FILMWP) and identified two novel mutations; one was a single
base insertion at codon 520 serine and the other was a single base
deletion at codon 403 tyrosine. Each mutation was confirmed and
demonstrated to cosegregate with the disease, using genomic
DNA together with sequence specific PCR primers. In addition,
the absence of these CLCN5 abnormalities in 30 alleles from 20
(10 males and 10 females) unrelated, normal individuals estab-
lished that they were not common polymorphisms (data not
shown). We conclude that mutations in the CLCN5 gene are
responsible for the disease in some Japanese patients. Lloyd et al
reported CLCN5 mutations in three disorders of hypercalciuric
nephrolithiasis (Dent's disease, XRN and XLRH) [8]. We believe
that there is a possibility that FILMWP is a variant of Dent's
disease.
In the remaining two patients, no abnormal bands were de-
tected in any exons of the gene. This could reflect either incom-
plete sensitivity of mutation detection as PCR-SSCP or alterna-
tively could be accounted for by genetic heterogeneity. Further
studies on all exon sequencing and linkage analyses using poly-
morphic markers need to be done to clarify this issue.
Mutations in the CLCN5 gene generate diseases such as Dent's
disease, XLRH and XRN, however, the relationship between
genotype and phenotype remains unknown [8]. In patient L2, the
mutation results in a change of transmenibrane domain 11 (Dli)
and the absence of CLCS protein from the D12 to C-terminal
regions [81. In patient L3, the mutation results in change of the
D8-D9 loop and the D9, and the absence from the partial region
of D9 to the C-terminal region of CLC5 protein (Fig. 3).
Accordingly, although expression of CLCN5 mutations in the
patients was not performed, it is speculative that mutations are
causative for the disease. Clinical symptoms of patient L2 were
more severe than those of patient L3, while the deleted portion of
CLC5 protein in patient L3 was greater than that in patient L2.
The severity of mutation did not seem to correlate with that of
clinical features.
Of 14 Japanese patients with FILMWP, four had localized
calcification in the tubulus (about 28.6%), and renal failure did
not occur in 16 during a follow-up of four years and two months
[15]. Clinical features of FILMWP are similar to those of Dent's
disease. However, there are notable differences of clinical pheno-
type; in Japanese families, rickets or renal failure do not occur.
This may be accounted for by differences of not only CLCN5
mutations but also environmental factors such as diet, especially
the quantity of calcium intake, or the length of exposure to the
sun. Further investigations of CLCN5 expression along the human
nephron, and of mechanisms whereby CLCN5 mutations lead to
LMW proteinuria, hypercalciuria and renal failure, will lead to
increased understanding of renal tubular function and pathology.
In the L2 family, the mother and the father had the same
mutation. Since the gene is on X chromosome, the patient L2
should inherit the mutant allele from the mother. Although we
were unable to document consanguinity, it is likely that the
mutation in family L2 arose from a common ancestor, because
both L2 mother and father families originated from the same
small island.
Our finding confirms that some cases of FILMWP are X-linked.
It is evident that urinary f32m is strikingly abnormal in the affected
males (> 10,000 j.rg/liter) and is less markedly abnormal in
heterozygous females (< 10,000 jig/liter) [15], while it is nearly
absent in normal controls (< 300 to 400 j.rg/liter) [16]. However,
some heterozygous females, such as the patient's sister (1112) in
family L3 and the patient's paternal aunt (15) in family L2, had
normal urinary f32m levels or p2m/creatinine ratio (0.11 gig/mg
creatinine). Further, urinary csl-microglohulin, one of the LMW
proteins, was 2.7 mg/liter (normal range 0.7 to 4.0 mg/liter) in 1112
of family L3. This might be accounted for by the Lyon hypothesis
of random inactivation of one X-chromosome in nephrons in
females. Without a gene analysis, they would he misdiagnosed as
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not being FILMWP heterozygotes. Analyses of the CLCN5 gene
will aid in diagnosing heterozygotes for FILMWP.
We conclude that the CLCN5 gene is responsible for the renal
proximal tubulopathy in some Japanese families, as well as three
disorders of hypercalciuric nephrolithiasis in Caucasians, and that
FILMWP is possibly a variant of Dent's disease.
During the submission process of our manuscript, Lloyd et al
reported several mutations in the CLCN5 gene from Japanese
patients with FILMWP associated with hypercalciuric riephrocal-
cinosis [171.
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APPENDIX
Abbreviations are: FILMWP, familial idiopathic low-molecular-weight
proteinuria; LMW, low molecular weight; XRN, X-linked recessive neph-
rolithiasis; XLRH, X-linked recessive hypophosphatemic rickets; fl2m,
beta-2 microglobulin.
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